Internal Server Error

List of Crown Laboratories's Acquisitions

lockFilter this list
Crown Laboratories has made a total of 11 acquisitions. These 11 acquisitions span 7 sectors, including Dermatology, Traditional Pharmaceuticals, and Beauty Tech, across United States and United Kingdom. Peak activity occurred in 2018 with 7 acquisitions, followed by 1 acquisition each in 2025 and 2022. The average number of acquisitions per year for the 2020–2025 period is 0.6, with 0 acquisitions completed in the current calendar year. In February 2025, it acquired Revance Therapeutics, a Newark-based developer of neurotoxin aesthetic and therapeutic skin treatments founded in 2002.

Here's the year on year acquisition history of Crown Laboratories:

Year on year acquisition history of Crown Laboratories20252022202120192018Acquisitions Round Date (Yearly)0246810
  • Number of Total Acquisitions
Year
# Acquisitions
2025
1
2022
1
2021
1
2019
1
2018
7

Recent acquisitions by Crown Laboratories

Crown Laboratories's most recent acquisition - Revance Therapeutics is a Developer of neurotoxin aesthetic and therapeutic products for skin treatments, founded in 2002 and located in Newark. Crown Laboratories acquired it in February 2025 for a price of $*****.

Here is the list of all acquisitions by Crown Laboratories sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Feb 08, 2025
uira
jeya
89
230
Aug 18, 2022
kwgq
xups
74
342
Aug 26, 2021
ibhs
cwxc
17
159
May 22, 2019
epy{
pteo
84
708
Dec 03, 2018
scwi
scaw
84
253

View the full list of acquisitions

Sign Up for Free

FAQs about Acquisitions by Crown Laboratories

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford